Healthcare -
Biotechnology - NASDAQ - FR
$ 1.8355
-2.53 %
$ 154 M
Market Cap
-2.76
P/E
IPHA - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss IPHA - Innate Pharma S.A.
495 K
LAST VALUE
4.19%
2 YEAR CAGR
19.63%
5 YEAR CAGR
31.12%
10 YEAR CAGR